Recursion's Q3 Earnings Beat Estimates on Sanofi Milestone Revenues

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect

Viatris Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

UBS Maintains Neutral on Iovance Biotherapeutics, Raises Price Target to $8

Neurocrine Biosciences Q3 Earnings Call Highlights

Iovance Gears Up to Report Q3 Earnings: Here's What to Expect

ETON Gears Up to Report Q3 Earnings: What Can Investors Expect?

SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus

Why Did IOVA Stock Jump Over 10% After-Hours Today?

Iovance Biotherapeutics (IOVA) Emerges as a Top Quant Pick Ahead of Earnings with Strong Price-to-Sales Signal

Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

Iovance Sinks Another 11% as Baird Cuts Target to $9 After Lung Cancer Data

Iovance Biotherapeutics (IOVA) Posts 59.1% Response In Lifileucel Lung Cancer Study

GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales Growth

INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised Guidance